IL133643A0 - Therapeutic method for management of diabetes mellitus - Google Patents

Therapeutic method for management of diabetes mellitus

Info

Publication number
IL133643A0
IL133643A0 IL13364398A IL13364398A IL133643A0 IL 133643 A0 IL133643 A0 IL 133643A0 IL 13364398 A IL13364398 A IL 13364398A IL 13364398 A IL13364398 A IL 13364398A IL 133643 A0 IL133643 A0 IL 133643A0
Authority
IL
Israel
Prior art keywords
management
diabetes mellitus
therapeutic method
therapeutic
mellitus
Prior art date
Application number
IL13364398A
Other languages
English (en)
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of IL133643A0 publication Critical patent/IL133643A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13364398A 1997-06-23 1998-04-08 Therapeutic method for management of diabetes mellitus IL133643A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/880,945 US5929055A (en) 1997-06-23 1997-06-23 Therapeutic method for management of diabetes mellitus
PCT/US1998/006927 WO1998058658A1 (fr) 1997-06-23 1998-04-08 Procede therapeutique destine a traiter le diabete sucre

Publications (1)

Publication Number Publication Date
IL133643A0 true IL133643A0 (en) 2001-04-30

Family

ID=25377455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13364398A IL133643A0 (en) 1997-06-23 1998-04-08 Therapeutic method for management of diabetes mellitus

Country Status (9)

Country Link
US (1) US5929055A (fr)
EP (1) EP1017414A4 (fr)
JP (1) JP2002511864A (fr)
KR (1) KR20010020497A (fr)
AU (1) AU744846B2 (fr)
CA (1) CA2294169A1 (fr)
IL (1) IL133643A0 (fr)
MX (1) MXPA99011821A (fr)
WO (1) WO1998058658A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9902721A2 (hu) * 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
WO2000018353A2 (fr) * 1998-09-28 2000-04-06 The Research Foundation Of State University Of New York Nouvel inhibiteur de formation de cataracte
US20040143015A1 (en) * 2001-03-12 2004-07-22 Villhauer Edwin Bernard Combination of organic compounds
US20040115261A1 (en) * 2001-04-05 2004-06-17 Ashley Robert A. Controlled delivery of tetracycline compounds and tetracycline derivatives
FR2826278B1 (fr) * 2001-06-20 2005-03-25 Lipha Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
EP1397124B1 (fr) * 2001-06-20 2006-11-29 Merck Sante Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
EP2332549A1 (fr) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Nouvelle tetracyclines et leur utilisation en médicine
EP1572126A4 (fr) * 2001-12-21 2006-07-05 Smithkline Beecham Corp Compositions et methodes servant a modifier la production de glucose
WO2003057169A2 (fr) 2002-01-08 2003-07-17 Paratek Pharmaceuticals, Inc. Composes de 4-dedimethylamino tetracycline
CN102531948A (zh) 2002-03-08 2012-07-04 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
AU2003218243B2 (en) 2002-03-21 2010-04-01 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
KR101148415B1 (ko) 2002-07-12 2012-05-21 파라테크 파마슈티컬스, 인크. 3, 10, 및 12ａ 치환된 테트라시클린 화합물
EP1615622B1 (fr) 2003-04-07 2012-07-11 Supernus Pharmaceuticals, Inc. Formulations de doxycyclines en dose quotidienne unique
EP2298322A3 (fr) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Composés de tétracycline substitués
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
CA2553510C (fr) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Derives a cycle aromatique a provenant de composes de tetracycline
CA2585418A1 (fr) 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines et procedes d'utilisation
EP2284156A3 (fr) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Composés de tétracycline substituée
US20070093455A1 (en) * 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
US20070098763A1 (en) * 2005-10-11 2007-05-03 Sinnott Robert A Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
CA2925939C (fr) 2006-12-21 2019-10-01 Paratek Pharmaceuticals, Inc. Composes de tetracycline substituee
ES2701725T3 (es) * 2006-12-21 2019-02-25 Paratek Pharm Innc Compuestos de tetraciclina sustituida para el tratamiento de trastornos inflamatorios de la piel
EP2216323A3 (fr) 2007-04-27 2010-12-29 Paratek Pharmaceuticals, Inc. Procédés de synthèse et de purification de composés d'aminoalkyle de tétracycline
BRPI0823405A2 (pt) * 2007-07-06 2012-12-25 Paratek Pharm Innc mÉtodos para sintetizar compostos de tetraciclina substituÍda
TW202332671A (zh) 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
AR072990A1 (es) 2008-08-08 2010-10-06 Tetraphase Pharmaceuticals Inc Compuestos de tetraciclina sustituidos con fluor en c7
CN107021887A (zh) 2009-05-08 2017-08-08 四相制药公司 四环素类化合物
WO2011025982A2 (fr) 2009-08-28 2011-03-03 Tetraphase Pharmaceuticals, Inc. Composés tétracycline
EP2552890B1 (fr) 2010-03-31 2017-01-04 Tetraphase Pharmaceuticals, Inc. Composés polycycliques de tétracycline
NZ740051A (en) 2012-08-31 2019-09-27 Tetraphase Pharmaceuticals Inc Tetracycline compounds
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
WO2017031440A1 (fr) 2015-08-20 2017-02-23 Aseko, Inc. Conseiller de thérapie pour la gestion du diabète
SG11201903327PA (en) 2016-10-19 2019-05-30 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline
US20210395198A1 (en) 2018-11-09 2021-12-23 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof
EP3968785A4 (fr) 2019-05-14 2023-01-11 Tyme, Inc. Compositions et méthodes de traitement du cancer
CA3179419A1 (fr) * 2020-04-08 2021-10-14 Hoffman Technologies Llc Procedes de traitement d'etats caracterises par une deficience en insuline chez des animaux
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985005036A1 (fr) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Traitement topique du diabete a l'aide d'insuline et d'un agent ameliorant la penetration applique sur la peau et recouvert d'une pastille
US5045538A (en) * 1990-06-28 1991-09-03 The Research Foundation Of State University Of New York Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
CA2103189C (fr) * 1992-11-17 2005-05-03 Lorne M. Golub Inhibition des liaisons croisees du collagene en exces au cours du diabete par des tetracyclines, y compris par des tetracyclines non antimicrobiennes chimiquement modifiees
AU1209995A (en) * 1993-11-17 1995-06-06 Duke University Medical Center Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
AU720662B2 (en) * 1995-04-07 2000-06-08 Albert Einstein College Of Medicine Of Yeshiva University Recombinant B-cell and uses thereof

Also Published As

Publication number Publication date
KR20010020497A (ko) 2001-03-15
JP2002511864A (ja) 2002-04-16
AU6889998A (en) 1999-01-04
AU744846B2 (en) 2002-03-07
EP1017414A1 (fr) 2000-07-12
MXPA99011821A (es) 2002-07-02
EP1017414A4 (fr) 2004-10-06
WO1998058658A1 (fr) 1998-12-30
US5929055A (en) 1999-07-27
CA2294169A1 (fr) 1998-12-30

Similar Documents

Publication Publication Date Title
IL133643A0 (en) Therapeutic method for management of diabetes mellitus
ZA983176B (en) Therapeutic compounds
EP0879279A4 (fr) Therapie des diabetes
IL137105A0 (en) Method for administering aspb28-human insulin
ZA981343B (en) Sulfonylurea-glitazone combinations for diabetes
AU1289799A (en) Method for administering acylated insulin
IL122718A0 (en) Methods for treating diabetes
AU2805195A (en) Therapeutic compounds
AU1673297A (en) Therapeutic agent for diabetes
GB9401436D0 (en) Therapeutic heterocyclic compounds
ZA958608B (en) Method of treating diabetes mellitus using kgf
HUP0002062A3 (en) Method for diagnosing bone dysbolism
GB9719161D0 (en) New therapeutic method
AU7718398A (en) Apparatus for positioning patients
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
AU2440599A (en) Therapeutic agent for complication of diabetes
EP1042004A4 (fr) Procede de perfusion tissulaire
GB9719189D0 (en) New therapeutic method
GB9719176D0 (en) New therapeutic method
GB2304046B (en) Diabetes therapy
GB9515060D0 (en) Therapeutic heterocyclic compounds
GB9719163D0 (en) New therapeutic method
GB9719167D0 (en) New therapeutic method
AUPO878097A0 (en) Treatment for diabetes